Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: Rocketman who wrote (895)	3/6/1999 6:18:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 3202

An excellent post, in fact, anybody reading my two cents right now--well go back and read Rocketman's note again instead. When I read that thing I really got kinda burned up. It was particularly annoying to me that Glaxo was one of these big cap pharmas leading the charge --Glaxo had to shell out all of 3M a few months ago to do a deal with Curagen (3M plus royalites if products result). Geeze, these guys are breaking my heart, 3M is nothing, they're lucky there are companies like CRGN and GLGC which are willing to sell the data so cheap. Frankly, I think the whole thing is a smoke screen-- anybody remember the CRGN/Glaxo rumor on Biofind a few weeks ago? Nuff said. End of rant, I will go away peacefully now. But be sure of one thing...if any of my micros ever come in, you can bet I'll be adding a little INCY to my basket, hell I'll probably re-activate my options account and dabble in incy calls as well.